{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Waltham",
      "address_1": "920 Winter St",
      "reason_for_recall": "Risk of Alkalosis with acetate containing dialysis acid  concentrates",
      "address_2": "",
      "product_quantity": "",
      "code_info": "All lots",
      "center_classification_date": "20120625",
      "distribution_pattern": "Nationwide Distribution and the country of Guam.",
      "state": "MA",
      "product_description": "Fresenius NaturaLyte Liquid Acid Concentrate  Product Codes:   08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8,08-3201-4,08-3231-1,08-3251-9,08-3301-2,08-4123-1, 08-4223-7, 08-4225-1' 08-4230-2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0,   13-3231-1,13-3251-9, 13-4123-1' 13-4220-1, 13-4225-1 ' 13-4325-1.    For the treatment of acute and chronic renal failure during hemodialysis procedure.",
      "report_date": "20120704",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Fresenius Medical Care Holdings, Inc.",
      "recall_number": "Z-1826-2012",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "62108",
      "termination_date": "20170720",
      "more_code_info": "",
      "recall_initiation_date": "20120329",
      "postal_code": "02451-1521",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}